Species diversity and clinical relevance of nontuberculous mycobacterium isolated from pulmonary and extrapulmonary samples in southeastern Turkey, 2014 to 2023: A retrospective cross-sectional study.

Species diversity and clinical relevance of nontuberculous mycobacterium isolated from pulmonary and extrapulmonary samples in southeastern Turkey, 2014 to 2023: A retrospective cross-sectional study.

Publication date: Jul 18, 2025

Infection with nontuberculous mycobacterium (NTM) has been on the rise worldwide. Although the incidence rate of NTM infection has increased, little is known about its species diversity and clinical significance. Investigating the variety and load of NTM species in pulmonary and extrapulmonary clinical isolates from a community in southeast Turkey is the goal of this study. The prevalence of NTM and the clinical significance of pulmonary NTM (PNTM) are evaluated in this cross-sectional study. Matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) and multiplex PCR were used to identify NTM species. Between 2014 and 2023, a total of 30,539 clinical samples from 14,586 tuberculosis (TB)-suspected patients were analyzed. Among the 1159 mycobacterial isolates, 85. 25% were identified as Mycobacterium tuberculosis complex (MTBC), while 14. 75% were identified as NTM. Of the NTM isolates, 88. 88% were pulmonary, while 11. 11% were extrapulmonary. The majority of NTM isolates consisted of slow-growing species (67. 84%). MTBC rate has decreased while the NTM rate has increased over the years. Of the 171 NTM isolates, identification was performed for 66 isolates. Overall, 16 different NTM species were identified. The most frequently isolated species were Mycobacterium simiae 28. 78% (19/66), Mycobacterium avium complex 21. 21% (14/66), and Mycobacterium abscessus complex 13. 63% (9/66). Among the 66 patients with NTM isolation, the mean age was 39 (+/-23. 10). On applying the American Thoracic Society/Infectious Disease Society of America (ATS/IDSA) criteria to determine the clinical relevance of the 61 patients with PNTM isolation, only 36. 06% had nontuberculous mycobacterial pulmonary disease (NTMPD), and the majority were caused by M. simiae (40. 9%). Chronic obstructive pulmonary disease was significantly more common in the American Thoracic Society criteria -positive group (22. 7%, P = . 004). Nodular bronchiectatic patterns occurred significantly more often in the American Thoracic Society criteria-positive group (77. 3%, P

Open Access PDF

Concepts Keywords
Mycobacterium Adult
Pulmonary Aged
Spectrometry Clinical Relevance
Turkey Cross-Sectional Studies
Female
Humans
Male
Middle Aged
Mycobacterium
Mycobacterium Infections, Nontuberculous
Nontuberculous Mycobacteria
nontuberculous mycobacterium
Prevalence
pulmonary disease
Retrospective Studies
Turkey
Young Adult

Semantics

Type Source Name
disease MESH clinical relevance
disease MESH Infection
disease MESH tuberculosis
pathway KEGG Tuberculosis
disease MESH Infectious Disease
pathway REACTOME Infectious disease
disease MESH pulmonary disease
disease MESH Chronic obstructive pulmonary disease
drug DRUGBANK Methyprylon
disease MESH Diabetes mellitus
disease MESH Malignancy
disease MESH AIDS
disease IDO immunodeficiency
disease MESH histiocytic sarcoma
disease MESH Autoimmune diseases
disease MESH systemic lupus erythematosus
pathway KEGG Systemic lupus erythematosus
disease MESH ankylosing spondylitis
disease MESH rheumatoid arthritis
pathway KEGG Rheumatoid arthritis
disease MESH myasthenia gravis
drug DRUGBANK Azathioprine
disease MESH Primary ciliary dyskinesia
drug DRUGBANK Coenzyme M
disease IDO country
disease IDO pathogen
drug DRUGBANK Dimercaprol
disease MESH Weight loss
disease MESH Bronchiectasis
disease MESH Asthma
pathway KEGG Asthma
disease IDO history
disease MESH Mycobacterium Infections Nontuberculous

Original Article

Leave a Comment

Your email address will not be published. Required fields are marked *